Results 261 to 270 of about 501,321 (365)

High HBsAg clearance rate and viral dynamics in HBeAg-positive, ALT-normal children and adolescents with chronic HBV infection: results from the prospective sprout project. [PDF]

Emerg Microbes Infect
Wang X, Lai C, Li R, Lei J, Xie Y, Li Z, Tang Q, He Q, Zhang H, Zhang Z, Wang F.   +10 more
europepmc   +1 more source

Metabolism of the Third Component of Complement in Acute Type B Hepatitis, HBs Antigen Positive Glomerulonephritis, Polyarteritis Nodosum, and HBs Antigen Positive and Negative Chronic Active Liver Disease

, 1979
Howard C. Thomas, Barry J. Potter, Elwyn Elias, S. Sherlock   +3 more
openalex   +1 more source

Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis

Rheumatology &Autoimmunity, EarlyView.
Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis. Abstract Both immunoglobulin (Ig) G4‐related disease (IgG4‐RD) and antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) are systemic disorders that affect a wide range of organs.
Wenhuan Zeng, Mingxin Bai, Yanying Liu
wiley   +1 more source

The recent advances in vaccine adjuvants. [PDF]

Front Immunol
Xing J, Zhao X, Li X, Fang R, Sun M, Zhang Y, Song N.   +6 more
europepmc   +1 more source

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing

Small, EarlyView.
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa, Mamata Karmacharya, Hyunmin Choi, Sumit Kumar, Yoon‐Kyoung Cho   +4 more
wiley   +1 more source

Diagnosis and Management of Autoimmune Hepatitis After Hepatitis A in a Young Woman. [PDF]

Am J Case Rep
Patel S, Dixon C, Chokshi N, Giraldo S, Thiriveedi M, Dailey V.   +5 more
europepmc   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

Small, Volume 21, Issue 29, July 24, 2025.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai, Dhwani Rana, Mitali Patel, Neha Bajwa, Rajendra Prasad, Lalitkumar K. Vora   +5 more
wiley   +1 more source

The status of occult HBV infection in a high endemic region: risk of community HBV transmission and reactivation. [PDF]

BMC Res Notes
Kafeero HM, Ocama P, Ndagire D, Walusansa A, Namusoke M, Kudamba A, Muwanda F, Sendagire H.   +7 more
europepmc   +1 more source

Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components

Small Methods, EarlyView.
The review presents a comprehensive overview of each component of lipid nanoparticles（LNPs）and their effects on editing efficiency. It specifically highlights strategies for achieving non‐liver delivery, aiming for broader applications in gene editing. Furthermore, this review summarizes the applications of LNPs in gene editing and offers insights for ...
Fan Wu, Nei Li, Yudian Xiao, Rohan Palanki, Hannah Yamagata, Michael J. Mitchell, Xuexiang Han   +6 more
wiley   +1 more source

Elucidating the role of autoreactive T cells and B cells in autoimmune hepatitis. [PDF]

J Clin Invest
Yasumizu Y, Hafler DA.
europepmc   +1 more source